全文获取类型
收费全文 | 35579篇 |
免费 | 2417篇 |
国内免费 | 756篇 |
专业分类
耳鼻咽喉 | 660篇 |
儿科学 | 857篇 |
妇产科学 | 418篇 |
基础医学 | 1602篇 |
口腔科学 | 874篇 |
临床医学 | 2634篇 |
内科学 | 5069篇 |
皮肤病学 | 1157篇 |
神经病学 | 1621篇 |
特种医学 | 3835篇 |
外科学 | 4778篇 |
综合类 | 2681篇 |
现状与发展 | 1篇 |
预防医学 | 2035篇 |
眼科学 | 619篇 |
药学 | 4664篇 |
10篇 | |
中国医学 | 469篇 |
肿瘤学 | 4768篇 |
出版年
2024年 | 36篇 |
2023年 | 332篇 |
2022年 | 708篇 |
2021年 | 1192篇 |
2020年 | 944篇 |
2019年 | 1359篇 |
2018年 | 1460篇 |
2017年 | 1090篇 |
2016年 | 996篇 |
2015年 | 1006篇 |
2014年 | 1676篇 |
2013年 | 2316篇 |
2012年 | 1554篇 |
2011年 | 1582篇 |
2010年 | 1266篇 |
2009年 | 1361篇 |
2008年 | 1386篇 |
2007年 | 1339篇 |
2006年 | 1088篇 |
2005年 | 918篇 |
2004年 | 792篇 |
2003年 | 897篇 |
2002年 | 1648篇 |
2001年 | 1911篇 |
2000年 | 2084篇 |
1999年 | 1368篇 |
1998年 | 1352篇 |
1997年 | 1220篇 |
1996年 | 693篇 |
1995年 | 432篇 |
1994年 | 228篇 |
1993年 | 193篇 |
1992年 | 166篇 |
1991年 | 166篇 |
1990年 | 144篇 |
1989年 | 149篇 |
1988年 | 125篇 |
1987年 | 121篇 |
1986年 | 109篇 |
1985年 | 205篇 |
1984年 | 195篇 |
1983年 | 173篇 |
1982年 | 134篇 |
1981年 | 139篇 |
1980年 | 127篇 |
1979年 | 121篇 |
1978年 | 56篇 |
1977年 | 50篇 |
1976年 | 48篇 |
1975年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 244 毫秒
61.
重组结核分支杆菌16000蛋白抗原(rPA16)的免疫原性研究 总被引:3,自引:0,他引:3
目的:研究结核分枝杆菌重组16000蛋白(rPA16)诱发家兔产生抗体的能力并评价其血清学诊断的价值。方法:家兔按注射的抗原及佐剂的不同分组,皮下多点注射分别进行免疫,6次免疫后采血,双向琼脂扩散试验和酶联免疫吸附试验(ELISA)跟踪兔血清抗体效价的时间效应并检测兔血清与所试各类分支杆菌PPD有无交叉反应;同时检测rPA16与各分支杆菌PPD的免疫羊血清的反应,并用rPA16抗原检测人血标本,分析该抗原的临床检测的敏感性和特异性。结果:兔血清抗体效价结果显示:5个月后,加佐剂的抗原组的兔免疫血清仍能检测到抗体,不加佐剂组2个月后血清抗体检测即为阴性,ELISA检测兔免疫血清比双向琼脂扩散方法要更敏感,rPA16抗原加佐剂引起的兔血清抗体滴度最高可达1:6400,不加佐剂组的血清抗体滴度仅为1:400,ELISA法分析抗rPA16的兔血清的特异性表明其特异笥较好,仅与牛、人型结核分支杆菌的PPD呈阳性反应,与其他所试分支杆菌PPD反应均为阴性,同时又分析了rPA16抗原的特异性,与人型PPD相比,该抗原只与所试各类分支杆菌,BCG、牛分支杆菌免疫的血清呈阳性反应,而人型PPD则基本上与结核分支杆菌免疫的血清均呈阳性反应,ELISA检测血清标本结果:肺结核病组中rPA16和PPD检测敏感性分别为64.8%和75.2%;健康组,卡介苗接种阳转健康组,rPA16和PPD检测特异性分别为96.2%,88.5%和94.3%,66.7%。结论:rPA16具有较强的免疫原性和一定的特异性,可能成为结核病血清学诊断试剂之一。 相似文献
62.
目的 :研究tritonWR 13 3 9致小鼠高脂血症时血清二乙基对硝基苯磷酸酯酶 (ParaoxonaseI ,PON 1)活性的变化及PON 1活性与血浆脂质含量之间的关系。方法 :在小鼠尾静脉注射tritonWR13 3 9后的 3h ,6h ,12h ,2 4h ,48h ,72h ,眼球摘除术取血 ,用酶标法测定小鼠血浆总胆固醇 (TC) ,甘油三酯 (TG ) ,高密度脂蛋白 -胆固醇 (HDL -C) ,载脂蛋白AI (ApoAI) ,载脂蛋白B (ApoB含量 ) ,并计算出ApoAI/ApoB ,HDL -C/TC比值 ,用分光光度计法测定PONI活性。结果 :TritonWR 13 3 9尾静脉注射后 3h ,小鼠血浆TC和TG含量即急剧增高 ,与对照组相比 ,P <0 .0 1,分别在注射后 2 4h和 3h达到峰值 ,随后逐渐下降 ,其中血浆TG含量在注射后 48h即恢复正常水平。tritonWR13 3 9尾静脉注射后 3h ,小鼠血浆HDL -C和ApoB含量急剧增高 ,与对照组相比 ,P <0 .0 5,分别在注射后 2 4h和 6h达到峰值 ,随后逐渐下降 ,分别在注射后 48h和 72h恢复正常水平。tritonWR13 3 9尾静脉注射后 3h ,小鼠血浆ApoAI含量即急剧降低 ,与对照组相比 ,P <0 .0 5,随后逐渐增高 ,在注射后 6h即恢复正常水平。tritonWR 13 3 9尾静脉注射后 3h ,小鼠血浆ApoAI/ApoB和HDL-C/TC比值减少 ,与对照组相比 ,P <0 .0 1,随后逐渐增高 ,其中ApoAI/ApoB比值在 72h恢复 相似文献
63.
《Journal of labelled compounds & radiopharmaceuticals》2005,48(9):693-700
[(1R)‐endo]‐(+)‐3‐bromocamphor was dehalogenated with tritium gas to [3‐3H]camphor and via [3‐3H]phenylborneol converted to [3‐3H]deramciclane isolated as the fumarate salt (specific activity 51.8 GBq/mmol). This three step synthesis from [3‐3H]camphor gave an overall yield of 22%. Benzyloxy‐acetic acid methyl ester was reduced with sodium‐borotritide to 2‐benzyloxy‐ethanol‐[1‐3H], and through a four step procedure was converted to 2‐dimethylaminoethyl‐[2‐3H] chloride. The latter was condensed with the sodium derivative of 2‐phenylborneol giving rise to [2‐dimethylamino‐[2‐3H]ethoxy]deramciclane isolated as the fumarate (specific activity 8.177 GBq/mmol). This six step synthesis from [3H]NaBH4 gave an overall yield of 6%. Copyright © 2005 John Wiley & Sons, Ltd. 相似文献
64.
多层螺旋CT胸部低剂量扫描对气道三维重建的应用研究 总被引:5,自引:1,他引:4
目的:比较低剂量与常规剂量条件下中央气道三维重建图像的差别,探讨低剂量螺旋CT扫描进行中央气道三维重建的可行性。材料和方法:32例病例行低剂量(50mAs)平扫及常规剂量(195mAs)平扫(1例)及增强扫描(31例),将两组原始数据分别普通算法及高分辨算法重叠重建出4组横断面图像,并进行气道SSD及VR重建,由两名放射科医师分析4组图像的质量、支气管显示情况、支气管病变检出情况,将结果进行统计学分析。结果:①图像质量:两组剂量间SSD图像质量无明显差异,高分辨重建图像质量≥普通算法重建图像质量;VR图像质量两种剂量之间无明显差异,高分辨算法图像质量≥标准算法重建图像质量。②支气管显示:两名医生评价结果均表明对段以上支气管显示方面无论SSD图像还是VR图像,低剂量与常规剂量组以及两种算法图像之间均无明显差异。③病变检出:无论SSD还是VR图像4组图像对支气管病变的检出无差异。④剂量差别:低剂量扫描比常规剂量扫描辐射剂量大大降低(13.6~3.6mGy)。结论:与常规剂量扫描相比,低剂量薄层扫描气道三维重建图像质量、对中央气道显示及病变检出都无明显差异,而病人接受的辐射剂量却大大降低,因此低剂量薄层扫描气道三维重建可以代替常规剂量重建图像应用于临床气道病变显示。 相似文献
65.
66.
目的探讨中药当归、川芎、黄芪、丹参提取液对大鼠放射性骨髓损伤的防护作用.方法雄性SD大鼠60只,随机分为正常对照组、模型组、中药组,每组6只,在相同条件下饲养2周,模型组和中药组大鼠给予6.0 Gy 60Co γ射线一次性全身照射,继续饲养1周处死全部动物并取材.用骨髓细胞计数法计数骨髓有核细胞数,用Western blot法测定血管内皮生长因子(vascularendothelialgrowth factor,VEGF)、血小板衍生生长因子(ptatelet derived growth factor,PDGF)的蛋白含量.结果与正常对照组比较,模型组大鼠的骨髓有核细胞数、VEGF、PDGF蛋白含量明显减少(P<0.01),与模型组比较,中药组大鼠的骨髓有核细胞数、VEGF、PDGF蛋白含量明显增加(P<0.01或P<0.05).结论中药当归、黄芪、川芎、丹参对大鼠放射性骨髓损伤有一定防护作用. 相似文献
67.
Andries S. Koster 《Pharmacy World & Science》1991,13(3):123-126
Quinones can be metabolized by various routes: substitution or reductive addition with nucleophilic compounds (mainly glutathione and protein thiol groups), one-electron reduction (mainly by NADPH: cytochrome P-450 reductase) and two-electron reduction (by D,T-diaphorase). During reduction semiquinone radicals and hydroquinones are formed, which can transfer electrons to molecular oxygen, resulting in the formation of reactive oxygen intermediates and back-formation of the parent quinone (redox cycling). Reaction of semiquinones and reactive oxygen intermediates with DNA and other macromolecules can lead to acute cytotoxicity and/or to mutagenicity and carcinogenicity. The enhanced DNA-alkylating properties of certain hydroquinones are exploited in the bioreductive alkylating quinones. Acute cytotoxicity of quinones appears to be related to glutathione depletion and to interaction with mitochondria and subsequent disturbance of cellular energy homoeostasis and calcium homoeostasis. These effects can to a certain extent be predicted from the electron-withdrawing and electron-donating effects of the substituents on the quinone nucleus of the molecule. Prediction of cytostatic potential remains much more complicated, because reduction of the quinones and the reactivity of the reduction products with DNA are modulated by the prevailing oxygen tension and by the prevalence of reducing enzymes in tumour cells.This article is based on a lecture given at the 16th LOF Symposium, 27 October 1989, Utrecht, the Netherlands. 相似文献
68.
The purpose of this study was to determine the dosimetric impact of a neurosurgical titanium mesh in patients treated with 6- and 18-MV photon beams. The effects of a 0.4-mm-thick titanium mesh on the dose profile at 3 regions within a solid water phantom were measured using extended dose range-2 (EDR2) film for 6- and 18-MV photon beams. All measurements were performed with the titanium mesh placed at a depth of 1.5 cm in the phantom. Films were exposed immediately above the mesh, immediately below the mesh, and at a depth of 5 cm from the surface of the phantom. The films were scanned using a scanning densitometer. In the region directly above the titanium mesh, there was an increase in dose of 7.1% for 6-MV photons and 4.9% for 18-MV photons. Directly below the titanium mesh, there was an average decrease in dose of 1.5% for 6-MV photons and an increase of 1.0% for 18-MV photons. At 5-cm depth, for 6- and 18-MV photons, there was a decrease in dose of 2.2% and 0.6%, respectively. We concluded that for cranial irradiation with high-energy photons, the dosimetric impact of a 0.4-mm titanium mesh is small and does not require modification in treatment parameters. 相似文献
69.
Alemtuzumab (CAMPATH 1H) Induction Therapy in Cadaveric Kidney Transplantation—Efficacy and Safety at Five Years 总被引:2,自引:0,他引:2
Christopher J. E. Watson J. Andrew Bradley Peter J. Friend John Firth Craig J. Taylor John R. Bradley Kenneth G. C. Smith Sathia Thiru Neville V. Jamieson Geoff Hale Herman Waldmann Roy Calne 《American journal of transplantation》2005,5(6):1347-1353
Alemtuzumab is a powerful lymphocyte depleting antibody currently being evaluated in solid organ transplantation. This paper describes 5-year results of a single center study of alemtuzumab as induction in renal transplantation. Thirty-three renal transplant recipients received 20 mg alemtuzumab on day 0 and 1, followed by half-dose cyclosporin monotherapy (trough concentration 75-125 ng/mL) from day 3. They were compared in a retrospective contemporaneous-controlled manner with 66 kidney transplant recipients transplanted in the same period and center who received conventional immunosuppression with cyclosporin, azathioprine and prednisolone. In the alemtuzumab group 12% of recipients died compared to 17% in the control group (p = 0.48); likewise graft loss was similar in both groups (21% vs. 26%, respectively, p = 0.58). Incidence of acute rejection was also comparable at 5 years (31.5% vs. 33.6%), although the pattern of rejection was different with 14% patients in the alemtuzumab group experiencing rejection over 1 year post-transplant compared to none in the control group. There was no significant difference between groups in terms of infection or serious adverse events. While acknowledging the limitations of a relatively small single-center study, results suggest that alemtuzumab induction allowed satisfactory long-term patient and graft survival equivalent to that seen with standard triple immunosuppression, while avoiding steroid therapy. 相似文献
70.
唾液腺放射性损伤及其防护 总被引:2,自引:0,他引:2
放射治疗在头颈肿瘤的地位已得到广泛认同,但放疗并发症不容忽视,最常见的是放射性口干。其主要机制为放射诱导的唾液腺损伤,早期和晚期损伤的机制不同。目前对唾液腺放射防护的研究主要集中在放射防护剂、放射技术、基因转移技术等多个方面。 相似文献